China CAS NO 1919837-50-5 Factory

Our corporation has been specializing in brand strategy. Customers' gratification is our greatest advertising. We also source OEM company for CAS NO 1919837-50-5,1919837-50-5,Baricitinib intermediate,Baricitinib advance intermediate,2-(1-(Ethylsulfonyl)-3, We attend seriously to produce and behave with integrity, and with the favor of consumers at your house and abroad during the xxx industry.
CAS NO 1919837-50-5, Adhering to the principle of "Enterprising and Truth-Seeking, Preciseness and Unity", with technology as the core, our company continues to innovate, dedicated to providing you with the highest cost-effective solutions and meticulous after-sales service. We firmly believe that: we're outstanding as we have been specialized.

Hot Products

  • Cefazolin Acid

    Cefazolin Acid

    Product Name:Cefazolin Acid
    Molecular Formula:C14H14N8O4S3
    Molecular Weight:454.51
    CAS Registry Number:25953-19-9
  • (S)-3-(MethylaMino)-1-(2-thienyl)-1-propanol

    (S)-3-(MethylaMino)-1-(2-thienyl)-1-propanol

    Product Name:(S)-3-(MethylaMino)-1-(2-thienyl)-1-propanol
    Molecular Formula:C8H13NOS
    Molecular Weight:171.26
    CAS Registry Number:116539-55-0
  • Hydroxychloroquine

    Hydroxychloroquine

    Product Name:Hydroxychloroquine
    Molecular Formula:C18H26ClN3O
    Molecular Weight:335.88
    CAS Registry Number:118-42-3
  • Sodium acetate

    Sodium acetate

    Product Name:Sodium acetate
    Molecular Formula:C2H3NaO2
    Molecular Weight;82.03379
    CAS Registry Number;127-09-3
  • Potassium chloroplatinate

    Potassium chloroplatinate

    Product Name:Potassium chloroplatinate
    Molecular Formula:Cl6KPt-
    Molecular Weight:446.88
    CAS Registry Number:16921-30-5
  • NEODYMIUM

    NEODYMIUM

    Product Name:NEODYMIUM
    Molecular Formula:Nd
    Molecular Weight:144.24
    CAS Registry Number:7440-00-8

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept